At approximately 8.5 mm in diameter, the future dominant follicle is ''selected'' for continued growth in cattle. In the present study, cows were treated with a gonadotropin-releasing hormone receptor antagonist, acyline, just before follicle selection (near 7.8 mm) to investigate the role of LH in changing mRNA concentrations during selection of a dominant follicle. The ovaries containing the expected dominant follicle (EDF; first largest follicle) and expected largest subordinate follicle (ESF) were removed after 12 or 24 h of treatment. Real-time PCR was used to determine mRNA concentrations. ELISA was used to measure testosterone and 17beta-estradiol (E 2 ) and radioimmunoassay to measure androstenedione (A 4 ) in follicular fluid. Concentrations of E 2 were greater in EDF than in ESF of untreated cows near the time of follicle selection (12 h) or at 12 h after selection (24 h). Testosterone, E 2 , and A 4 were all dramatically decreased by acyline treatment at both times. In theca cells, acyline treatment reduced CYP17A1 (P450 17alpha) in EDF and STAR (steroidogenic acute regulatory protein) in both EDF and ESF but did not alter CYP11A1 (P450scc). In granulosa cells (GCs), LHCGR (luteinizing hormone [LH] receptor) was much greater in EDF than in ESF at both time of selection (739% greater) and 12 h after selection (2837% greater) and was decreased by acyline in EDF (87% decrease). The mRNA for CYP19A1 (cytochrome P450 aromatase) and PAPPA (pregnancyassociated plasma protein-A) tended to be greater in EDF than in ESF at follicle selection, and both mRNAs were much greater at 12 h after selection, with acyline significantly decreasing PAPPA mRNA after 24 h of treatment. The mRNA for FSHR (folliclestimulating hormone receptor) was not different in EDF versus ESF and was not altered by acyline. Thus, induction of LHCGR mRNA in GCs is an early event during the follicle selection process, and surprisingly, expression of LHCGR mRNA is dependent on circulating LH. Production of follicular A 4 , testosterone, and E 2 are also acutely related to LH but due to changes in expression of STAR and CYP17A1 in TC.
INTRODUCTION
Luteinizing hormone (LH) is critical not only for ovulation and luteinization of the dominant follicle but also for normal growth and development of a competent dominant follicle. The action of LH on theca cells is one important way that LH regulates follicular development. LH stimulates the expression of steroidogenic enzymes, including STAR (steroidogenic acute regulatory protein), CYP11A1 (cytochrome P450 side-chain cleavage), and CYP17A1 (cytochrome P450 17a hydrolase), that are essential for production of androgens by theca cells [1, 2] . In addition, granulosa cells are also regulated by LH following a dramatic induction of LH receptors in granulosa cells as part of the molecular events associated with selection of a single dominant follicle [3] . For example, an exogenous LH surge will only cause ovulation of a follicle after follicular deviation has occurred (diameter, ;10 mm) [4] . In granulosa cells, LH regulates the mRNA concentrations for numerous genes that function in steroidogenesis, autocrine and paracrine signaling, intracellular signal transduction, cytoskeletal regulation, and apoptosis [5, 6] .
Evidence from mutations in humans and knock-out mouse models also supports a critical role of LH in follicular development. Histological examination of ovaries from women with an inactivating mutation of LHCGR (LH receptor) indicated that all stages of follicular development (primordial, preantral, and antral) were present; however, preovulatory follicles and corpora lutea were not [7] . Ovarian follicles of Lhcgr knock-out mice did not develop beyond the early antral stage [8, 9] . Furthermore, in primates, LH appears to be important for the final stages of follicular development up until ovulation in primates [10, 11] . Thus, in primates or mice, normal follicular development to the preovulatory stage requires the action of LH.
In cattle and sheep, evidence also indicates that the final stages of follicular development require LH pulses. In cattle, the use of transrectal ultrasound has allowed precise characterization of the dynamics of follicle growth beginning at follicular diameters of 3-4 mm. Clearly, follicles emerge as a wave of growing follicles in response to an elevation in follicle-stimulating hormone (FSH) [12, 13] . This FSH elevation reaches a nadir near the time that has been termed follicular deviation-that is, when a single dominant follicle is selected from the wave of follicle growth [12] . Follicular deviation in cattle occurs, on average, at the time the largest follicle reaches 8.5 mm in diameter. When cows received long-term treatment with a gonadotropin-releasing hormone (GnRH) agonist or GnRH antagonist, the follicles did not grow past the point of follicular deviation [14, 15] . Furthermore, most [16] [17] [18] , but not all [19] , studies have indicated that the induction of LHCGR mRNA in granulosa cells occurs close to the expected time of follicular deviation (diameter, ;8.5 mm). In addition, analysis of LHCGR splice variants in cattle indicated that functional LHCGR mRNA variants in granulosa cells only were observed after selection of a dominant follicle [18] . Thus, these results are generally consistent with the hypothesis that follicle growth after the time of follicular deviation is dependent upon LH pulses acting on LHCGR in granulosa cells. Nevertheless, the molecular and physiological mechanisms regulated by LH pulses in follicle selection and the final stages of follicle development are still not completely defined.
The present study was designed to test the effect of reducing circulating LH by acute treatment with a GnRH antagonist on steady-state mRNA concentrations near the time of follicular deviation. This research provides further information on the timing of specific molecular changes that occur in follicular cells during selection of a single dominant follicle, an area of substantial previous research. Nevertheless, to our knowledge, no previous study has investigated the role of LH pulses in the molecular changes that are associated with follicle selection. This research has both basic and practical implications given that abnormal LH secretion underlies multiple types of anovulatory infertility in many species [20] [21] [22] . To validly test the hypothesis that LH pulses are critical for the changes in mRNA concentrations that occur during follicle selection, it is critical that acute treatment with GnRH antagonist be done very near the expected time of follicle selection using a monovular species, such as human or cow.
MATERIALS AND METHODS

Animal Procedure and Experimental Design
Nonlactating, nonpregnant Holstein cows (n ¼ 22) were used in the present experiments. They were housed in a stanchion barn at the University of Wisconsin-Madison Dairy Research Center. All animal handling and care procedures were approved by the Research Animal Resource Center of University of Wisconsin-Madison.
Ovarian ultrasonographic examinations were performed as described using a real-time, B-mode scanner equipped with a 7.5-MHz, linear-array, intrarectal transducer (Aloka 900V; Corometrics Medical Systems, Inc.) [23] . Measurements were made on two frozen images of the apparent maximal areas of each follicle using the average diameter in two directions at right angles. Follicle ablations were done transvaginally by ultrasound-guided follicle entry using an ultrasound device (Aloka SSD-500V; Aloka) with a 5-MHz, convex-array, transvaginal transducer (Aloka UST974V-5) [24] . The follicular contents were removed with a 17-gauge needle using a vacuum pump (250-300 mm Hg). Follicle ablation was defined as complete collapse of the follicular antrum after evacuation, with no subsequent return of that antrum found during the ultrasound evaluation on the next day.
Reproductive cycles of cows were synchronized with Ovsynch as previously described [25] ; briefly, cows were treated with 100 lg GnRH, followed 7 days later with 25 mg prostaglandin F 2a , followed 2 days later with a second treatment of 100 lg GnRH; ;28 h later, synchronized ovulation was achieved. A new follicular wave emerges at approximately the same time as the synchronized ovulation, and all follicles in this follicular wave were ablated on Day 9 after the second GnRH treatment of the Ovsynch protocol. A new follicular wave emerged at approximately 24 h after follicular aspiration.
After aspiration, all growing follicles (diameter, !4 mm) of the new or postablation wave were tracked every 6 h to maintain individual identity of growing follicles. A map of the location and size of all follicles on both ovaries was produced. When the largest follicle reached 7.8 mm or greater in diameter, the cows were randomly assigned to one of four treatment groups: group 1, control cows that received a saline injection and ovariectomy 12 h after treatment; group 2, cows treated with acyline (GnRH antagonist) as a single i.m. injection (3 lg/kg body wt) and ovariectomy 12 h after treatment; group 3, control cows that underwent ovariectomy at 24 h after saline treatment; group 4, acyline-treated cows that underwent ovariectomy at 24 h after treatment. Preliminary results (Fig. 1) showed that treatment with this dose of acyline completely prevented the LH and FSH surge associated with injection of 100 lg of GnRH (an ovulatory dose of GnRH). The specific times were chosen because a diameter of 7.8-8.0 mm represents a time approximately 8-12 h before follicular deviation; therefore, it was expected that the 12-h time point would be close to the expected time of deviation and the 24-h time point approximately 12-16 h after deviation. Ovariectomy was performed using the colpotomy technique [26] at 12 and 24 h after acyline (or saline) treatment using an ecraseur (Jorgensen Laboratories, Inc.).
Isolation of Follicular Cells and mRNA
Ovaries were immediately placed on ice, and the first and second largest follicles from the pair of ovaries were identified and isolated. Follicular fluid was aspirated from the follicles and stored at À808C until assayed for testosterone and 17b-estradiol (E 2 ). After aspiration, follicles were bisected and granulosa cells removed by gently scraping the internal surface of the follicular wall with a sterile rubber policeman, while the follicle was in a Petri dish filled with Medium 199. Cells were then collected by centrifugation (400 3 g), rapidly frozen in liquid nitrogen, and stored at À808C until mRNA was isolated. The remaining follicle walls were washed and shaken vigorously three times to remove any residual granulosa cells. Follicle halves were then examined under a dissecting microscope, and the theca interna layer was gently peeled away from the basement membrane, frozen in liquid nitrogen, and stored at À808C until mRNA was isolated [27] .
Messenger RNA was isolated from the collected granulosa cells and theca interna layer using Magnetight oligo (dT) magnetic beads (Novagen). Cells were lysed with 200 ll of lysis buffer (4 M guanidine isothiocyanate, 0.1 M Tris [pH 8.0], 1% dithiothreitol, and 0.5% N-lauroylsarcosine) and neutralized with 400 ll of binding buffer (100 mM Tris [pH 8.0], 400 mM NaCl, and 20 mM ethylenediaminetetra-acetic acid [EDTA]). Samples were centrifuged at 16 000 3 g for 5 min at 48C to pellet cellular debris. The supernatant of each sample was transferred to two tubes containing 50 ll of oligo (dT) beads and allowed to hybridize for 10 min. Beads were then captured on a magnetic stand and washed three times with 300 ll of wash buffer (10 mM Tris [pH 8.0], 150 mM NaCl, and 1 mM EDTA). The mRNA was eluted by heating 10 ll of elution buffer (2 mM EDTA) to 658C for 5 min, and the isolated mRNA was stored at À808C.
RT and Real-Time PCR
Reverse transcription was performed in a 20-ll volume of RT master mix that contained 13 RT reaction buffer, 5 lM random hexamer primers, 200 lM dNTP, 40 U of Moloney murine leukemia virus reverse transcriptase (Promega), and 2 ll of mRNA sample [28] . The RT reaction was carried out at 378C for 1.5 h, followed by heating to 958C for 10 min in a programmable thermocycler (MJ Research).
Steady-state concentrations of investigated mRNAs were quantified by realtime PCR using a GeneAmp 5700 Sequence Detection System (PE Biosystems), with PCR products detected using SYBR Green I (Molecular Probes). Primers for amplification were designed using Primer Express (PE Biosystem). Each PCR reaction mix (25 ll) contained 13 PCR buffer (Promega) with 1:20 000 dilution of SYBR Green I, 1. [29] . Thermal cycling conditions were 948C for 30 sec; followed by 40 cycles at 948C for 30 sec, 578C for 30 sec, and 728C for 30 sec; and finally, 728C for 10 min. Melting-curve analyses and agarose gel electrophoresis were performed after real-time PCR reactions to monitor PCR product purity. Primers for investigated genes are listed in Table  1 . The primers for LH receptor amplified a sequence located in exon 9 that is common to all isoforms and, therefore, would not distinguish between functional and nonfunctional isoforms of the LH receptor [18] .
The threshold cycle (C T ) numbers were determined for the amplified cDNA for each investigated gene mRNA and for the housekeeping gene, RPLP0 (acidic ribosomal phosphoprotein), in each unknown sample during real-time PCR [30] . The relative quantification of investigated steady-state mRNA concentrations was evaluated using a standard-curve method [31] . For each sample, the amount of investigated gene mRNA and the housekeeping gene mRNA (RPLP0) was determined from the standard curve. A normalized mRNA value was then calculated by dividing the amount of investigated gene mRNA by the amount of RPLP0.
Hormone Assays
Analyses of testosterone and E 2 in follicular fluid were done using competitive ELISA assays that have been described previously [32] . Briefly, 96-well plates were coated with goat anti-mouse immunoglobulin (Ig) G for testosterone assay and with goat-anti-sheep IgG for E 2 assay. Plates were then washed, and a mouse antibody against testosterone was added for testosterone assay (Biostride, Inc.) and a sheep antibody against E 2 for E 2 assay (Animal Reproduction and Biotechnology Laboratory, Colorado State University). Horseradish peroxidase was conjugated to testosterone and E 2 [33] and used in competitive assays with the steroids from a 1:100 dilution of follicular fluid. Subsequently, 3,3 0 ,5,5 0 -tetramethylbenzidine was used to quantify horseradish peroxidase activity. Androstenedione (A 4 ) was analyzed in 1:100 dilution of follicular fluid using the Coat-A-Count Direct Androstenedione assay (Diagnostic Products Corporation).
Serum concentrations of LH and FSH were determined using radioimmunoassays validated for use in cattle [34, 35] . The LH assay incorporated USDAbLH-B-6 for iodination and reference standards and USDA-309-684p as the primary antiserum. Assay sensitivity, calculated as two SD below the mean counts per minute at maximum binding, was 0.06 ng/ml. Coefficients of variation for within and between assays for LH were 5.4% and 6.3%, respectively, using pooled plasma from cows near estrus (mean, 2.1 ng/ml of LH). USDA-bFSH-I-2 was used for the FSH assay as the iodination and reference standards, and NIDDK-anti-FSH-I-2 was used as the primary antiserum. Assay sensitivity was 0.05 ng/ml (mean of two different assays). Coefficients of variation for within and between assays for FSH were 4.1% and 7.8%, respectively.
Statistical Analyses
Comparisons of LH and FSH concentrations between control and treatments at 12 and 24 h were performed with unpaired t-tests. The ANOVA procedure in SAS (Statistical Analysis Software) was used to analyze the differences among expected dominant follicle (EDF; first largest follicle) and expected largest subordinate follicle (ESF) in control and treatment groups, followed by a Fisher least-significant-difference test for separating means. The MIXED procedure in SAS was used to evaluate the main effects of treatment, hour, and treatment 3 hour interaction on LH and FSH concentrations in the experiment for determining the optimal acyline dose. For all statistical analyses, P , 0.05 was considered to be statistically significant, and P , 0.10 was considered to be a tendency. Values are presented as mean 6 SEM.
RESULTS
Changes in Hormonal Concentrations
In the preliminary experiment, treatment with 100 lg of GnRH resulted in a large increase in LH (.100-fold increase) and FSH (.2.5-fold increase) concentrations (Fig. 1 ). Although treatment with 1 lg/kg of acyline did not completely block the action of GnRH, treatment with 3 and 10 lg/kg of acyline resulted in complete suppression of GnRH-induced LH and FSH secretion (Fig. 1) . In a second preliminary experiment, we treated cows with saline or 3 lg/kg of acyline and, 24 h later, challenged cows with 100 lg of GnRH. Again, treatment with acyline completely suppressed the GnRHinduced increase in LH and FSH concentrations (data not shown). Therefore, the 3 lg/kg dose of acyline was utilized in the main experiment.
During the main experiment, treatment with acyline resulted in a decrease in circulating LH concentrations at 12 h (control vs. acyline, 0.83 6 0.13 vs. 0.49 6 0.09 ng/ml; P , 0.01) or 24 h (control vs. acyline, 0.95 6 0.08 vs. 0.57 6 0.06 ng/ml; P , 0.01) after treatment. However, no differences were found in circulating FSH concentrations at 12 h (control vs. acyline, 0.87 6 0.08 vs. 0.85 6 0.05 ng/ml) or 24 h (control vs. acyline, 0.97 6 0.05 vs. 0.87 6 0.07 ng/ml) after acyline treatment.
Follicular fluid concentrations of A 4 , testosterone, and E 2 in the EDF and ESF are shown in Figure 2 . In control cows, substantial variation in A 4 and testosterone concentrations was found between follicles ( Fig. 2A) , as demonstrated by the large SEMs. Concentrations of A 4 and testosterone were not significantly different between the EDF and ESF in control cows at either 12 or 24 h; numerically, however, the A 4 and testosterone concentrations were greater in the ESF than in the EDF at both 12 and 24 h (Fig. 2, A and B) . Follicular fluid A 4 concentrations in the EDF were much lower in cows treated with acyline than in control cows at 12 h (99% decrease; P ¼ 0.000075) and at 24 h (99% decrease; P ¼ 0.0011) after treatment ( Fig. 2A) . In cows treated with acyline, much lower concentrations of follicular fluid testosterone were found in the LH REGULATION OF FOLLICULAR mRNA CONCENTRATIONS 371 EDF (93% decrease; P ¼ 0.0026) and ESF (93% decrease; P ¼ 0.0089) at 12 h after treatment and in the EDF (92% decrease; P ¼ 0.024) at 24 h after treatment (Fig. 2B) .
In control cows, greater concentrations of follicular fluid E 2 were found in the EDF than in the ESF (Fig. 2C) at both 12 h (near deviation) and 24 h (12 h after deviation). Nevertheless, the difference was larger at 24 h (570% greater in EDF than in ESF; P ¼ 0.036) than at 12 h (205% greater in EDF than in ESF; P ¼ 0.018) because of a 170% increase in E 2 concentrations in the EDF by 24 h. Similar to the observations regarding follicular fluid testosterone, acyline treatment decreased follicular fluid E 2 concentrations in both the EDF (84% decrease; P ¼ 0.018) and ESF (77% decrease; P ¼ 0.0077) at 12 h after treatment and in the EDF (94% decrease; P ¼ 0.0011) at 24 h after treatment.
Changes in mRNA Concentrations for Steroidogenic Enzymes
To determine the amount of cross-contamination of theca and granulosa cell preparations, both of the preparations from dominant follicles (12 and 24 h) were evaluated for CYP17A1 (theca cell specific) and CYP19A1 (granulosa cell specific In theca cells, the concentrations of mRNA for three different genes related to steroidogenesis, STAR, CYP11A1, and CYP17A1, were evaluated. At 12 h (Table 2 ) or 24 h (Table  3) after treatment, no significant differences were found when the EDF was compared to the ESF for these three theca cell mRNAs using follicles from either control or acyline-treated animals. However, acyline treatment had a dramatic effect on concentrations of mRNA for STAR and CYP17A1 in theca cells. At 12 h after treatment (Table 2) , theca cell STAR mRNA was greatly decreased by acyline in the EDF (82% decrease; P ¼ 0.019) and the ESF (66% decrease; P ¼ 0.037). Similarly, at 24 h after treatment (Table 3) , theca cell STAR mRNA continued to be decreased by acyline in the EDF (84% decrease; P ¼ 0.005) and in the ESF (83% decrease; P ¼ 0.002). Theca cell mRNA for CYP17A1 was significantly decreased by 12 h of acyline treatment in the EDF (59% decrease; P ¼ 0.027) but not in the ESF (33% decrease; P ¼ 0.186). By 24 h after treatment, acyline treatment significantly decreased theca cell mRNA for CYP17A1 in both the EDF (73% decrease; P ¼ 0.017) and the ESF (82% decrease; P ¼ 0.001). No differences were found in CYP11A1 mRNA in theca cells after 12 or 24 h of acyline treatment (Tables 2 and 3) .
In granulosa cells, the concentrations of mRNA for CYP19A1 were altered by selection of a dominant follicle (EDF vs. ESF) but only marginally changed by acyline treatment. At 12 h after treatment, a tendency was observed for greater CYP19A1 mRNA in the EDF versus the ESF (215% greater; P ¼ 0.084) in control cows. By 24 h, much greater CYP19A1 mRNA was found in the EDF than in the ESF (1474% greater; P ¼ 0.002) in control cows. At 12 h after treatment, acyline tended to decrease mRNA for CYP19A1 in both the EDF (54% decrease; P ¼ 0.084) and the ESF (53% decrease; P ¼ 0.110). By 24 h after treatment, the effect of acyline on CYP19A1 mRNA was not statistically significant in either the EDF (63% decrease; P ¼ 0.163) or the ESF (25% decrease; P ¼ 0.386).
Changes in Granulosa Cell mRNA for PAPPA and Gonadotropin Receptors
Changes were found in the granulosa cell PAPPA (pregnancy-associated plasma protein-A) mRNA concentrations that were related to both selection of a dominant follicle (EDF vs. ESF) and acyline treatment. At 12 h (Table 2) , there tended to be greater PAPPA mRNA in granulosa cells from the EDF than in those from the ESF (297% greater; P ¼ 0.076). By 24 h (Table 3) , much greater PAPPA mRNA was found in granulosa cells from the EDF than in those from the ESF (398% greater; P ¼ 0.00026). At 12 h after treatment, acyline FIG. 2. Acyline effects on concentrations of A 4 (A), testosterone (B) and E 2 (C) in follicles during selection of a single dominant follicle in cow. First follicle, first largest follicle; second follicle, second largest follicle; 12h, 12-h treatment; 24h, 24-h treatment; GnRHant., GnRH receptor antagonist (acyline). An asterisk (*) indicates significant differences between control and treatment with GnRH receptor antagonist in the same type follicle (P , 0.05). A number symbol (#) indicates significant differences between dominant and subordinate follicles within the same treatments (P , 0.05).
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did not have a significant effect on PAPPA mRNA in either the EDF (39% decrease; P ¼ 0.213) or the ESF (31% increase; P ¼ 0.331). However, by 24 h after treatment, acyline significantly decreased PAPPA mRNA in the EDF (79% decrease; P ¼ 0.0079), with a similar decrease found in PAPPA mRNA in the ESF that was not statistically significant (79% decrease; P ¼ 0.202).
The mRNA for FSHR (FSH receptor) in granulosa cells was not altered by selection of a dominant follicle, because the EDF and the ESF had similar FSHR mRNA at 12 or 24 h in either control or acyline-treated cows (Tables 2 and 3 ). In addition, acyline treatment for 12 or 24 h did not alter FSHR mRNA in granulosa cells. Figure 3 shows the steady-state mRNA concentrations for LHCGR in theca and granulosa cells. In theca cells (Fig. 3A) , a tendency was observed for a difference in LHCGR mRNA between the EDF and the ESF at 12 h (48% greater in EDF than in ESF; P ¼ 0.059) but not at 24 h (16% greater in EDF than in ESF; P ¼ 0.371). At 12 h after treatment, acyline decreased LHCGR mRNA in theca cells of the EDF (36% decrease; P ¼ 0.029). In granulosa cells (Fig. 3B) , LHCGR mRNA was much greater in the EDF than in the ESF at both 12 h (739% greater; P ¼ 0.03) and 24 h (2837% greater; P ¼ 0.028) in control cows. Moreover, control granulosa cells from the EDF had greater concentrations of LHCGR mRNA at 24 h (354% greater; P ¼ 0.048) than at 12 h. Acyline dramatically reduced the concentration of LHCGR mRNA at both 12 h (87% decrease; P ¼ 0.031) and 24 h (86% decrease; P ¼ 0.037) after treatments in granulosa cells of the EDF.
DISCUSSION
A number of the molecular changes occurring in follicular cells during the process of follicle selection have been reported [36] [37] [38] [39] ; however, the hormonal and molecular mechanisms responsible for these changes are incompletely defined. The present study examined the effect of inhibiting LH near the time of follicular deviation in the process of follicle selection. In this study, we collected granulosa and theca cells from follicles that were close to the earliest morphological manifestations of follicle selection, termed follicular deviation. This allowed further definition of changes associated with early follicular deviation. One of the most dramatic and earliest changes associated with the follicular deviation process was an increase in LHCGR mRNA in the granulosa cells of the dominant follicle, with more than 7-fold greater LHCGR mRNA in the EDF versus the ESF at the earliest time point evaluated (12 h, corresponding to a time within 8 h of follicular deviation). A less dramatic but significant difference was also found in follicular fluid E 2 concentrations between the EDF and the ESF. Other differences between dominant and subordinate follicles, such as increased mRNA concentrations of CYP19A1 and PAPPA in granulosa cells, did not reach significance until the 24-h time point, approximately 12-20 h after the start of follicular deviation.
Along with these intriguing data regarding the molecular changes associated with early follicle selection, the present study provided novel results concerning the molecular changes caused by acute inhibition of LH near the time of follicle selection by treatment with acyline, a long-acting, potent GnRH receptor antagonist of the azaline B family [40, 41] . The GnRH antagonist actions of acyline have been demonstrated previously in dogs [42] , horses [43] , cattle [44] , rodents [45] , monkeys [46] , and humans [47] . The actions of acyline in the present study likely are mediated by reduced LH pulses. However, any of the observed effects of acyline could be attributable to disruption of a local GnRH system, because GnRH, GnRH receptors, and effects of GnRH agonists have all been detected in the ovary [48] [49] [50] . In theca cells, treatment with acyline for only 12 h inhibited androgen production and mRNA concentrations of key steroidogenic enzymes associated with androgen production. In granulosa cells, surprisingly, the earliest effects were an increase in LHCGR mRNA, with later effects on PAPPA and, possibly, CYP19A1. Figure 4 summarizes the present results and some possible intracellular mechanisms mediating these changes. Although these results provide substantial insight regarding the putative role of LH in the process of follicle selection and other follicular events occurring around this process, they also raise some intriguing paradoxes about the intra-and intercellular mechanisms associated with this process.
It was not surprising that elimination of LH pulses dramatically decreased androgen production by theca cells. Treatment with the dose of GnRH receptor antagonist that was utilized in the present study was clearly effective in eliminating GnRH-induced LH and FSH release, as demonstrated in the preliminary experiments. During the main study, we did not take frequent blood samples; therefore, pulsatile LH secretion was not evaluated. Nevertheless, average LH concentrations were significantly reduced by acyline treatment, with no change in average FSH concentrations. In cattle and sheep, only the preovulatory FSH surge appears to be acutely dependent on GnRH stimulation, with concentrations of circulating FSH during most of the cycle regulated primarily by inhibitory molecules, particularly inhibin and to a lesser extent estrogen, acting directly on the pituitary gland [51] . Thus, acute treatments with a GnRH receptor antagonist do not decrease basal FSH during the normal estrous cycle of cattle [52] [53] [54] . The decrease in stimulation of theca cells by LH pulses during acyline treatment was expected to decrease androgen concentrations in follicular fluid, as was observed in the present study (Fig. 2) . This may be mediated by multiple mechanisms, but the decreased STAR and CP17A1 likely have a critical role in decreased androgen production by theca cells.
Given the extensive previous data supporting a role for LH and cAMP/protein kinase A (PKA) in regulating transcription of these genes, it also was not unexpected that mRNA for STAR and CYP17A1 were decreased after acyline treatment. The proximal region of the bovine STAR promoter has two steroidogenic factor 1 (SF1) elements, and this region mediates acute stimulation of this gene by LH [2] . In the mouse, the promoter region for Star has been found to have a cAMPresponsive region localized between À105 and À60 bp upstream of the transcriptional start site, with the functional elements SF1, CCAAT/enhancer-binding protein-b/nonconsensus activating protein-1/nuclear receptor half-site (CAN), and GATA4 [55] localized to this region. Transcription factors belonging to the CREB (cAMP-responsive element-binding protein) family have been found to directly associate with the CAN region, to induce gene expression following transcription factor phosphorylation, and to synergize with NR5A1 (also known as SF1) [56, 57] . In addition, two cAMP-responsive sequences are located in proximal regions of CYP17A1 [58] that may mediate LH/cAMP/PKA stimulation of CYP17A1 transcription. In contrast, despite evidence for putative cAMPresponse elements in the bovine CYP11A1 promoter and for stimulation of this promoter by cAMP [59] , no effect of acyline treatment on concentrations of CYP11A1 mRNA was found in the present study.
Our results concerning theca cells are consistent with those of a previous study that also tested the role of LH pulses in follicle growth [60] . Those researchers treated cows with a GnRH agonist until follicle growth greater than 5 mm in diameter was inhibited. Subsequently, cows were treated with continuous FSH infusion for 2 days, followed by 2 more days of FSH infusion with or without the addition of hourly LH pulses. Addition of LH pulses increased A 4 and E 2 concentrations in follicular fluid as well as CYP17A1 mRNA in theca cells [60] . Similar to our results, no effect of LH pulses on CYP11A1 mRNA was found.
Despite these clear effects of acyline on steroidogenesis by theca cells, it seems unlikely that selection of a single dominant follicle is caused by changes in theca cell production of androgen or the expression of mRNA for theca cell steroidogenic enzymes. In our experiment, no differences were found between the dominant and subordinate follicles in A 4 and testosterone concentrations in follicular fluid, with the only numerical differences favoring higher androgen concentrations in follicular fluid of subordinate follicles. In addition, the three steroidogenic enzymes that were evaluated in theca cells in the present study were not different between dominant and subordinate follicles. Thus, despite the critical importance of androgen as a substrate for follicular estrogen production and the important physiological actions of androgen within the follicle [61] , we found no evidence for androgen production being a rate-limiting step in follicle selection. This is consistent with previous results showing that cultures of follicle walls from dominant versus subordinate follicles did not differ in A 4 production but did demonstrate greater E 2 production by the dominant follicle [19] .
On the other hand, E 2 production by the dominant follicle does appear to be a key pathway associated with selection of a dominant follicle. In the present study, a higher concentration of E 2 in the future dominant follicle was an early event during follicle selection, consistent with previous results [19, 62] . In addition, CYP19A1 mRNA was dramatically greater in the EDF than in the ESF (statistically different by 24 h). Differences in E 2 concentrations likely are related to aromatase activity, given that androgen substrate did not differ between follicles and previous findings of greater aromatase activity in dominant compared to subordinate follicles [19] . The increase in follicular E 2 production associated with follicular deviation not only may be important in systemic hormonal regulation but also may have intrafollicular actions, such as increased CYP19A1 and decreased IGFBP4 (insulin-like growth factor binding protein-4) production in granulosa cells [61, [63] [64] [65] [66] . It was surprising that acyline treatment did not significantly alter steady-state mRNA concentrations of CYP19A1 given the previous in vitro data showing regulation of CYP19A1 mRNA concentrations in granulosa cells by cAMP/PKA pathways [67] . Similarly, addition of LH pulses for 2 days did not alter CYP19A1 mRNA in granulosa cells in the previous study using GnRH agonist treatment [60] . These results may indicate that LH/cAMP/PKA pathways are not sufficiently altered by removal of LH pulses (acyline treatment) or addition of LH pulses [60] , perhaps because of low numbers of LHCGR in granulosa cells during the treatment periods. The findings of no effect of acyline treatment but dramatic effects of follicle selection on CYP19A1 provide evidence that induction of CYP19A1 during follicle selection is not mediated by LH action in granulosa cells. Furthermore, it appears that distinct pathways may be involved in inducing LHCGR, PAPPA, and CYP19A1 mRNA during the follicle selection process because of differences in timing and acyline regulation of these different genes.
The role of the insulin-like growth factor (IGF) system in regulation of follicular development and selection has been clearly demonstrated in previous research [37] [38] [39] . For example, in Igf1 knock-out mice, follicular development was arrested at preantral/early antral stage without mature graafian or luteinized follicles detected and with Cyp19a1 mRNA concentrations that were dramatically reduced in follicles [68] . IGF1 was necessary for induction of CYP19A1 mRNA by FSH in cultured bovine granulosa cells [69] . Moreover, intrafollicular injection of IGF1 promoted subordinate follicles to become dominant follicles [70] . The IGFBP4 concentrations were lower in the expected future dominant follicle than in the largest subordinate follicles while diameters of those follicles were similar [62] . Intrafollicular bioavailability of IGF1 is primarily controlled by IGFBP concentrations, which are regulated by their expression and proteolysis in follicles [71] . An important regulator of proteolytic degradation of IGFBP4 and IGFBP5 in the follicle is PAPPA [63, 72] . In the present study, the expression of PAPPA mRNA was decreased by 24-h acyline treatment, implicating circulating LH, either directly or indirectly, in regulation of PAPPA transcription during follicle selection. Strikingly, we further found that granulosa cell PAPPA mRNA dramatically increased only in the dominant follicle during the time when the dominant follicle first began to deviate in growth rate from the subordinate follicle (from 12 to 24 h in our experiment). Thus, increases in PAPPA mRNA in granulosa cells are clearly associated with follicle selection, and LH appears to be involved in increasing concentrations of this mRNA. Nevertheless, the increase in granulosa cell LHCGR mRNA did appear to occur before the increase in PAPPA mRNA in the future dominant follicle, suggesting that pathways downstream of LH action, such as cAMP/PKA, may be important for expression of PAPPA mRNA in granulosa cells. Indeed, previous research has indicated that treatment of granulosa cells with forskolin, to increase cAMP, rapidly and dramatically increased PAPPA mRNA [73, 74] . In the mouse, steady-state concentrations of Pappa mRNA were dramatically stimulated by equine chorionic gonadotropin [75] , further implicating the cAMP/PKA pathway.
The most dramatic and intriguing results from the present study are related to concentrations of LHCGR mRNA in granulosa cells. The changes in expression of this receptor occurred soon after the time of deviation in growth rate of the future dominant and subordinate follicle (12-h time point in the present experiment). This is consistent with previous findings that granulosa cells in future dominant follicles have increased concentrations of LHCGR mRNA near the time of follicle selection [16] [17] [18] . The increase in LH receptor expression in granulosa cells could not be the result of theca cell contamination, because LH receptor expression in control EDF granulosa cells was 4-to 15-fold greater in granulosa cells than in theca cells (i.e., theca cell contamination would actually reduce, rather than increase, LH receptor concentrations in control EDF granulosa cells). Unexpectedly, concentrations of LHCGR mRNA in granulosa cells were dramatically reduced by acyline treatment. This is in stark contrast to concentrations of FSHR mRNA that were not different in granulosa cells of future dominant versus subordinate follicles and were not decreased even after 24 h of acyline treatment. Other researchers have also reported that FSHR mRNA concentra-LH REGULATION OF FOLLICULAR mRNA CONCENTRATIONS tions were not different in granulosa cells from follicles ranging from 7.5 to 15 mm in diameter during the first follicular wave [16, 76] . Our results do not support a rate-limiting role for FSHR expression in follicle selection but are more consistent with a role for induction of LHCGR in selection of a single dominant follicle.
A somewhat paradoxical result is that inhibition of LH pulses by acyline completely suppressed the induction of LHCGR in granulosa cells during selection of the dominant follicle, suggesting that LH promotes expression of its own receptors in vivo. This finding is supported by previous in vitro studies that showed LH treatment increased the number of LH receptors in FSH-primed rat granulosa cells [77] , but it is not consistent with a previous study [60] that found no effect of addition of LH pulses for 2 days on expression of LHCGR mRNA in granulosa cells. Numerous previous studies have reported an increase in LHCGR mRNA induced by FSH/cAMP in granulosa cells of multiple species [18, 74, 78] . Indeed, the proximal region of the rat Lhcgr gene contains multiple SP1 elements, including an SP1c adjacent sequence (SAS site), and the functional role of the SAS site, but not of SP1c, in cAMPstimulation of Lhcgr transcription has been demonstrated by mutational analysis of these sites using an Lhcgr promoterreporter gene system [79] . Furthermore, key repressors of the Lhcgr promoter have been identified. An pRb homologue, termed p107, was found to act as a repressor of Lhcgr, and release of this repressor (derepression) occurred after phosphorylation of SP1 mediated by phosphatidylinositol 3-kinase/ protein kinase Czeta. In addition, a rat direct repeat motif (rDR) and an initiator-like element can repress expression of Lhcgr gene [80, 81] . Two transcription factors, EAR2 and EAR3/ COUP-TFI/NR2F1, have been found to bind at the rDR site to repress LHCGR expression. Interestingly, human chorionic gonadotropin treatment reduced the repression of the LHCGR gene and, correspondingly, deceased the protein levels of EAR2 and EAR3/COUP-TFI/NR2F1 [81] . Furthermore, histone deacetylases (HDACs) have been found to directly dock to SP1-bound DNA elements and to silence the transcription of LHCGR. The inhibition by HDACs was potentiated by binding of mSin3A to HDACs [82] . Thus, regulation of expression of LHCGR by cAMP/PKA could occur either through direct promoters in the gene or through derepression of the promoter. Evidence also exists for a key role of LHCGR mRNA stability in the up-regulation of LHCGR mRNA in response to estrogen and FSH [65] , apparently because of direct binding of mevalonate kinase to LHCGR mRNA [83, 84] .
An alternative, but intriguing, possibility is that a theca cell product may be a key stimulator of LHCGR expression in granulosa cells. Pulses of LH near deviation could be an important stimulator of this theca cell product, and inhibition of LH by acyline may have reduced theca cell secretion of this regulator of granulosa cell differentiation. Indeed, evidence indicates that theca cell secretions regulate granulosa cells [61, [85] [86] [87] [88] . In addition, the effects of acyline treatment at 12 h were primarily observed in theca cells (STAR and CYP17A1) and not granulosa cells, except for the dramatic effects of 12 h of acyline treatment on LHCGR mRNA concentrations in granulosa cells. Nevertheless, the present study was not designed to designate which of these intriguing mechanisms might be involved in the dramatic regulation of LHCGR mRNA concentrations observed in response to selection of a dominant follicle or acyline treatment.
In contrast to LHCGR expression in granulosa cells, expression of LHCGR in theca cells occurs at very early stages of follicular development, including in preantral follicles [16, 76] . Previous studies have indicated that increases in LHCGR mRNA in theca cells may be related to selection of a dominant follicle [16, 76] , although changes in LHCGR in theca cells are not as dramatic as observed in granulosa cells. In the present study, no significant differences were found in concentrations of LHCGR mRNA in theca cells from dominant or subordinate follicles at 12 or 24 h, although a tendency for an increase in the EDF at 12 h was observed. In addition, only slight alterations in LHCGR mRNA in theca cells were noted after acyline treatment, suggesting that LH is not involved in the acute regulation of this gene in theca cells near the time of follicle selection. Furthermore, no differences were found between dominant and subordinate follicles in theca cell mRNA concentrations of STAR or CYP17A1, two genes that were dramatically regulated by acyline treatment (acute withdrawal of LH). All these results oppose the concept that a change in LH responsiveness/action in theca cells plays the pivotal role in selection of a single dominant follicle in cattle.
In conclusion, during selection of a single dominant follicle, LH pulses are required for maintenance of theca steroidogenic enzymes to produce androgen substrates for aromatase in granulosa cells (Fig. 4) . Induction of LHCGR on granulosa cells in the future dominant follicle is an early event in follicle selection, with this induction being, paradoxically, dependent upon LH action. The signaling from LH during the time period of follicle selection was found not only to be critical for expression of genes involved in androgen production in theca cells (STAR and CYP17A) but also to regulate PAPPA mRNA in granulosa cells.
